US$ 24.48
glp-1 receptor function Agonists as Treatments for Type 2 Diabetes GLP-1-based therapies for type 2
Description
, ,

Keeping a short log of when palpitations happen, how long they last, and what you were doing at the time gives a doctor the clearest picture of whether the symptom needs further workup
302, 881-888 Smith I, Hardy E, Mitchell S, Batson S

World J Diabetes 2022

hence, MRE-data for the primary endpoint were derived from 57 subjects at week 48

CrossRef La variabilit glycmique : un facteur de risque singulier conjuguer au pluriel Louis Monnier, Claude Colette, Fabrice Bonnet, David Owens Mdecine des Maladies Mtaboliques.2022
